News
NICE recommends Epidyolex for treatment of tuberous sclerosis complex
The CBD-based drug will now be prescribed through the NHS for seizures related to the condition.
Search
24 results for “nice”
News
“Breaking down barriers”: Parents welcome new NICE guidelines on medical cannabis
The parents of three-year-old Charlie Hughes have welcomed new guidelines clarifying that clinicians can prescribe medical cannabis. Matt and Ali Hughes have reached a settlement in their fight with the […]
Industry
NHS and NICE bosses to speak at UK medical cannabis summit
Health chiefs will address what comes next for medical cannabis in the UK at an industry conference later this year. In an industry first event, the Centre for Medical Cannabis […]
Case Studies
Why we’re taking NICE to court over cannabis denial
The parents of Charlie Hughes have seen cannabis medicine transform their two-year-old’s life. They are now gearing up for a legal battle to help them and other families access the treatment on the NHS.
Feature
NHS aims to remove medical cannabis barriers – while NICE dithers
A new ‘specialist network’ which aims to better support doctors in prescribing medical cannabis to children in the UK could be set up under new NHS recommendations.
Cannabis explained
Medical Cannabis for ADHD in the UK: How It Compares With Stimulants
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
News
Cannabis-Based Drug Receives First European Market Approvals for Chronic Back Pain
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
Insight
Bridging the Gap with Dr Sue Clenton: Measuring Care – Why Outcomes Matter More Than Opinions
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
Science
12 Things We’ve Learned About Medical Cannabis in 2025
Dr Simon Erridge reflects on some of the key findings published on medical cannabis this year.
News
Cannabis Health Symposium 2025: Key Takeaways Part 1
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
Insight
Why Real-World Evidence is Key in Medical Cannabis Research
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
Comment
Medical Cannabis Helped Me Recover from Major Surgery—and Opened Minds in the NHS
James Smith, co-founder of 4C Labs, shares his recent experience using cannabis-based medicines after a hip replacement.
News
UK Government Rejects Medical Cannabis ‘Grow Your Own’ Petition, But At What Cost?
Around 13,000 people signed a petition calling for ‘Grow Your Own’ laws in the UK.
News
Cannabis Executive Wins Legal Battle Against UK Border Force After Medication Seizure
Adam Windish is calling for law enforcement agencies to be better educated on medical cannabis.
Medical cannabis
How Releaf’s Rigorous Training Programme Ensures Patient Care
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner.
Medical cannabis
More Than Just a Private Prescription: NHS Spine Integration Brings Medical Cannabis into the System
Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this be a turning point in how clinicians view and engage with cannabis-based medicines?
News
Closing the Gap: How Real-World Evidence Could Reshape UK Medical Cannabis Policy
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could it help bridge the […]
Industry
New Data Supports Use Of Epidiolex In Tuberous Sclerosis Complex
Jazz Pharmaceuticals has shared new data on Epidiolex in patients with tuberous sclerosis complex (TSC).
Industry
Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major […]
News
NHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access
Six years on from the legalisation of medical cannabis in the UK, new figures reveal lack of NHS prescribing.
News
Economic analysis finds medical cannabis could save NHS £4 billion each year
The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain.
News
A new centre-left government and the potential for ‘change’ in the UK cannabis landscape
What does the new government mean for cannabis policy in the UK?
Pain
Cannabis terpenes can relieve chemotherapy-induced neuropathic pain – study
Researchers found that terpenes found in cannabis were as effective as morphine at reducing chronic neuropathic pain.
News
Cannabis-based medicines could be ‘cost-effective’ for treatment of chronic pain
Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.